Advertisement

Acute Parkinsonism

  • Hubert H. Fernandez
  • Joseph H. Friedman
Part of the Current Clinical Neurology book series (CCNEU)

Abstract

Patient 1: A 75-year-old woman with a history of bipolar affective illness dating back to her 20s was admitted to the hospital after falling and breaking her hip while walking her dog. She had been living alone. She underwent a total hip replacement without incident and was at her mental and physical baseline in the recovery room and then on the postsurgical floor. Two days after surgery she suddenly became mute, stiff, and unresponsive. In addition to her usual regimen of 600 mg lithium, 20 mg fluoxetine, and 4 mg trifluoperazine daily, she had received five doses of meperidine (50 mg/bolus intravenously) for pain control. She kept her eyes open and responded to visual threat and deep pain but not voice. She had markedly increased tone and was akinetic. When her arms were elevated, she slowly lowered them. Deep tendon reflexes were normal. Physical examination, vital signs, laboratory tests, including lithium levels and head computed tomography (CT) were unremarkable. She remained in this state for 3 days before a movement disorder consultation was requested.

Keywords

Neurol Neurosurg Psychiatry Neuroleptic Malignant Syndrome Viral Encephalitis Encephalitis Lethargica Akinetic Mutism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Friedman JH. Drug induced parkinsonism. In: Lang AE, Weiner WJ, eds. Drug Induced Movement Disorders. Futura, Mt Kisco, NY: 1992;41–84.Google Scholar
  2. 2.
    Fahn S, Przedborski S. Parkinsonism. In: Rowland LP, ed. Merritt’s Textbook of Neurology, 10th ed. Lippincott, Williams and Wilkins, Philadelphia: 679–693.Google Scholar
  3. 3.
    Caligiuri MP, Ellwanger J. Motor and cognitive aspects of motor retardation in depression. J Affect Disord 2000;47:83–93CrossRefGoogle Scholar
  4. 4.
    Hymas N, Lees A, Bolton D, et al. The neurology of obsessional slowness. Brain 1991;114:2203–2233.PubMedCrossRefGoogle Scholar
  5. 5.
    Curran T, Lang AE. Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature and pathophysiological hypotheses. Mov Disord 1994;9:508–520PubMedCrossRefGoogle Scholar
  6. 6.
    Riley D. Secondary parkinsonism. In:Jankovic JJ, Tolosa E, eds. Parkinson’s Disease and Movement Disorders, 4th ed. Lippincott, Williams and Wilkins, Philadelphia: 2002;199–211.Google Scholar
  7. 7.
    Boecker H, Weindl A, Leenders K, et al. Secondary Parkinsonism due to focal substantia nigra lesions: a PET study with (18F)FDG and (18F)Fluorodopa. Acta Neurol Scan 1996;93:387–392.CrossRefGoogle Scholar
  8. 8.
    Stern G. The effects of lesions in the substantia nigra. Brain 1966;89:449–478.PubMedCrossRefGoogle Scholar
  9. 9.
    Hunter R, Smith J, Thomson T, Dayan AD. Hemiparkinsonism with infarction of the ilpsilateral substantia nigra. Neuropathol Appl Neurobiol 1978;4:297–301.PubMedGoogle Scholar
  10. 10.
    Kim JS. Involuntary movements after anterior cerebral artery territory infarction. Stroke 2001;32:258–261.PubMedGoogle Scholar
  11. 11.
    Nagaratnam N, Davies D, Chen E. Clinical effects of anterior cerebral artery infarction. J Stroke Cerebrovasc Dis 1998;7:391–397.PubMedCrossRefGoogle Scholar
  12. 12.
    Dick JP, Benecke R, Rothwell JC, et al. Simple and complex movements in a patient with infarction of the right supplementary motor area. Mov Disord 1986;1:255–266.PubMedCrossRefGoogle Scholar
  13. 13.
    Russmann H, Vingerhoets F, Ghika J, et al. Acute infarction limited to the lenticular nucleus: clinical, etiologic and topographic features. Arch Neurol 2003;60:351–358PubMedCrossRefGoogle Scholar
  14. 14.
    Turjanski N, Pentland B, Lees AJ, Brooks DJ. Parkinsonism associated with acute intracranial hematomas: an (18F)Dopa positron-emission tomography study. Mov Disord 1997;12:1035–1038.PubMedCrossRefGoogle Scholar
  15. 15.
    Wang JD, Huang CC, Hwang YH, et al. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med 1989;46:856–859.PubMedGoogle Scholar
  16. 16.
    Feldman RG. Manganese. In: Occupational and Environmental Medicine. Lippincott Raven, Philadelphia: 168–188.Google Scholar
  17. 17.
    Sohn YH, Jeong Y, Kim HS, Im JH, Kim JS. The brain lesion responsible for parkinsonism after carbon monoxide poisoning. Arch Neurol 2000;57:1214–1218.PubMedCrossRefGoogle Scholar
  18. 18.
    Perry GF. Occupational medicine forum. What are the potential delayed health effects of high level carbon monoxide exposure? J Occup Med 1994;36:595–597.Google Scholar
  19. 19.
    Okuda B, Iwamoto Y, Tachibana H, Sugita M. Parkinsonism after acute cadmium poisoning. Clin Neurol Neurosurg 1997;99:263–265.PubMedCrossRefGoogle Scholar
  20. 20.
    Barbosa ER, Comerlatti LR, Haddad MS, Scaff M. Parkinsonism secondary to ethylene oxide exposure: case report. Arq Neurosiquiatr 1992;50:531–533.Google Scholar
  21. 21.
    Laplane D, Attal N, Sauron B, et al. Lesions of the basal ganglia due to disulfiram neurotoxicity. J Neurol Neurosurg Psychiatry 1992;44:925–929.CrossRefGoogle Scholar
  22. 22.
    Messing B. Extrapyramidal disturbance after cyanide poisoning. J Neural Transm Suppl 1991;33:141–147.PubMedGoogle Scholar
  23. 23.
    Pentore R, Venneri A, Nichelli P. Accidental choke-cherry poisoning: early symptoms and neurological sequelae of an unusual case of cyanide intoxication. Ital J Neurol Sci 1996;17:233–233.PubMedCrossRefGoogle Scholar
  24. 24.
    Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine analogue synthesis. Science 1983;219(4587):979–980.PubMedCrossRefGoogle Scholar
  25. 25.
    Leopold NA, Bara-Jimenez W, Hallett M. Parkinsonism after a wasp sting. Mov Disord 1999;14:122–127.PubMedCrossRefGoogle Scholar
  26. 26.
    Bogolepov NK, Luzhetskaya TA, Fedin AI, et al. Allergic encephalomyelopolyradiculoneuritis from a wasp sting (clinico-patholo report). Zh Nevropatol Psikhiatr Im SS Korsakova 1978;78:187–191.Google Scholar
  27. 27.
    Shandling M, Carlen PL, Lang AE. Parkinsonism in alcohol withdrawal: a follow up study. Mov Disord 1990;4:36–39.CrossRefGoogle Scholar
  28. 28.
    Carlen PL, Lee MA, Jacob M, Livishitz O. Parkinsonism provoked by alcoholism. Ann Neurol 1981;9:84–86.PubMedCrossRefGoogle Scholar
  29. 29.
    Lang AE, Marsden CD, Obeso JA, Parkes JD. Alcohol and parkinson disease. Ann Neurol 1982;12:254–256.PubMedCrossRefGoogle Scholar
  30. 30.
    Tinker R, Anderson MG, Anand P, et al. Pontine myelinolysis presenting with acute parkinsonism as a sequel of corrected hyponatremia. J Neurol Neurosurg Psychiatry 1990;53:87–89.PubMedGoogle Scholar
  31. 31.
    Dickoff DJ, Rapps M, Yahr MD. Striatal syndrome following hyponatremia and its rapid correction. Arch Neurol 1988;45:112–114.PubMedGoogle Scholar
  32. 32.
    Victor M, Ropper AH. Adam’s and Victor’s Principles of Neurology. 7th ed. McGraw Hill, New York: 2001;1193–1195.Google Scholar
  33. 33.
    Hawker K, Lang AE. Hypoxic-ischemic damage of the basal ganglia. Case reports and a review of the literature. Mov Disord 1990;5:219–224.PubMedCrossRefGoogle Scholar
  34. 34.
    Straussberg R, Shahar E, Gat R, Brand N. Delayed parkinsonism associated with hypotension in a child undergoing open-heart surgery. Dev Med Child Neurol 1993;35:1007–1014.Google Scholar
  35. 35.
    Li JY, Lai PH, Chen CY, et al. Postanoxic parkinsonism: clinical radiologic and pathologic correlation. Neurology 2000;55:591–593.PubMedGoogle Scholar
  36. 36.
    Carbone JR. The neuroleptic malignant syndrome and serotonin syndromes. Emerg Clin No America 2000;18:317–325.CrossRefGoogle Scholar
  37. 37.
    Susman VL. Clin Management of neuroleptic malignant syndrome. Psychiatr Wkly 2001;72:325–326.Google Scholar
  38. 38.
    Lockman LA, Sung JH, Krivit W. Acute parkinsonian syndrome with demyelinating leukoencephalopathy in bone marrrow transplant recipients. Pediatr Neurol 1991;7:457–463.PubMedCrossRefGoogle Scholar
  39. 39.
    Devinsky O, Lemann W, Evans AC, et al. Akinetic mutism in a bone marrow transplant recipient following total-body irradiation and amphotericin B chemoprophylaxis. A positron emission tomographic and neuropathologic study. Arch Neurol 1987;44:414–417.PubMedGoogle Scholar
  40. 40.
    Chuang C, Constantino A, Balmaceda C, et al. Chemotherapy-induced parkinsonism responsive to levodopa: an underrrecognized entity. Mov Disord 2003;18:328–331.PubMedCrossRefGoogle Scholar
  41. 41.
    Shahar E, Goshen E, Tauber Z, Lahat E. Parkinsonian syndrome complicating systemic lupus erythematosus. Pediatr Neurol 1998;18:456–458.PubMedCrossRefGoogle Scholar
  42. 42.
    Yancey CL, Doughty RA, Athreya BH. Central nervous system involvement in childhood system lupus erythematosis. Arthritis Rheum 1981;24:1389–1395.PubMedCrossRefGoogle Scholar
  43. 43.
    Friedman JH. Stereotypy and Catatonia. In: Jankovic JJ, Tolosa E, eds. Parkinson’s Disease and Movement Disorders. Third Edition. Williams and Wilkins, Baltimore, MD: 1998;709–729.Google Scholar
  44. 44.
    Bush G, Fink M, Petrides G, et al. Catatonia: 2. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996;93:137–143.PubMedCrossRefGoogle Scholar
  45. 45.
    Factor SA, Podskalny GD, Molho ES. Psychogenic movement disorders: frequency, clinical profile and characteristics. J Neurol Neurosurg Psychiatry 1994;59:406–412.Google Scholar
  46. 46.
    Trimble MR. Clinical Presentations in neuropsychiatry. Semin Clin Neuropsychiatry 2002;7:11–17.PubMedCrossRefGoogle Scholar
  47. 47.
    Lang AE, Koller WC, Fahn S. Psychogenic parkinsonism. Arch Neurol 1995;52:802–810.PubMedGoogle Scholar
  48. 48.
    Koller WC, Findley LI. Psychogenic tremors. Adv Neurol 1990;53:271–275.PubMedGoogle Scholar
  49. 49.
    Von Economo C. Encephalitis lethargica. Wien Klin Wochenschr 1917;30:581–585.Google Scholar
  50. 50.
    Urechia CL. Dix cas d’encephalite epidemique avec autopsie. Arch Inter Neurol 1921;2:65–78.Google Scholar
  51. 51.
    Cruchet R, Moutier F, Calmette A. Quarante cas d’encephalo-myelite subaigue. Bull Mem Soc Medd’Hop 1917;41:614–616.Google Scholar
  52. 52.
    Etienne G. Myelities aigues epidemiques. Deux epdiemies militares. Rev Neurol 1917;24:375–376.Google Scholar
  53. 53.
    Watson AJ. Origin of encephalitis lethargica. China Med J 1928;42:427–432.Google Scholar
  54. 54.
    Von Economo C. Encephalitis lethargica: its sequelae and treatment (translated by K.O. Newman) Oxford University Press, London: 1931;I–XIV, 1–200.Google Scholar
  55. 55.
    Duvoisin RC, Yahr MD. Encephalitis and parkinsonism. Arch Neurol 1965;12:227–239.PubMedGoogle Scholar
  56. 56.
    Geddes JF, Hughes AJ, Lees AJ, Daniel SE. Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. Brain 1993;116:281–282.PubMedCrossRefGoogle Scholar
  57. 57.
    Wilson SAK. Epidemic encephalitis. In: Neurology, Vol 1. Williams and Wilkins, Baltimore: 1940;118–165.Google Scholar
  58. 58.
    Morrison PJ, Patterson VH. Cranial dystonia (Meige syndrome) in postencephalitic parkinsonism. Mov Disord 1992;7:90–91.PubMedCrossRefGoogle Scholar
  59. 59.
    Wenning GK, Jellinger K, Litvan I. Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism. J Neurol Transm 1997;104:845–865.CrossRefGoogle Scholar
  60. 60.
    Litvan I, Jankovic J, Goetz CG. Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study. Eur J Neurol 1998;5:451–457.PubMedCrossRefGoogle Scholar
  61. 61.
    Duncan AG. The sequelae of encephalitis lethargica. Brain 1924;47:76–108.CrossRefGoogle Scholar
  62. 62.
    Calne DB, Lees AJ. Late progression of post-encephalitic parkinson syndrome. Can J Neurol Sci 1988;15:135–138.PubMedGoogle Scholar
  63. 63.
    Vieregge P, Reinhardt V, Hoft B. Is progression in postencephalitic Parkinson’s disease late and age-related? J Neurol 1991;238:299–303.PubMedGoogle Scholar
  64. 64.
    Ravenholt RT, Foege WH. 1918 Influenza, encephalitis lethargica, parkinsonism. Lancet 1982;2:860–862.PubMedCrossRefGoogle Scholar
  65. 65.
    Laidlaw PP. Epidemic influenza: a virus disease. Lancet 1935;1:1118–1124.CrossRefGoogle Scholar
  66. 66.
    Casals J, Elizan TS, Yahr MD. Postencephalitic parkinsonism-a review. J Neural Transm 1998;105:645–676.PubMedCrossRefGoogle Scholar
  67. 67.
    Gamboa ET, Wolf A, Yahr MD, et al. Influenza virus antigen in postencephalitic parkinsonism brain. Arch Neurol 1974;31:228–232.PubMedGoogle Scholar
  68. 68.
    Martilla RJ, Halomen P, Rinne UK. Influenza virus antibodies in parkinsonism. Comparison of postencephalitic and idiopathic parkinson patients and matched controls. Arch Neurol 1977;34:99–100.Google Scholar
  69. 69.
    Elizan T, Schwartz J, Yahr MD, Casals J. Antibodies against arboviruses in postencephalitic and idiopathic Parkinson’s disease. Arch Neurol 1978;35:257–260.PubMedGoogle Scholar
  70. 70.
    Takahashi M, Yamada T, Nakajima S, et al. The substantia nigra is a major target for neurovirulent influenza A virus. J Exp Med 1995;181:2161–2169.PubMedCrossRefGoogle Scholar
  71. 71.
    Elizan TS, Casals J, Yahr MD. Antineurofilament antibodies in postencephalitic and idiopathic Parkinson’s disease. J Neurol Sci 1983;59:341–347.PubMedCrossRefGoogle Scholar
  72. 72.
    Elizan TS, Yahr MD. Histocompatibility antigens and postencephalitic parkinsonism. J Neurol Neurosurg Psychiatry 1983;46:688–693.PubMedGoogle Scholar
  73. 73.
    Lees AJ, Stern GM, Compston DAS. Histocompatibility antigens and post-encephalitic parkinsonism. J Neurol Neurosurg Psychiatry 1982;45:1060–1061.PubMedGoogle Scholar
  74. 74.
    Williams A, Houff S, Lees A, Calne DB. Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic parkinsonism. J Neurol Neurosurg Psychiatry 1979;42:790–792.PubMedGoogle Scholar
  75. 75.
    Rail D, Scholtz C, Swash M. Postencephalitic parkinsonism: current experience. J Neurol Neurosurg Psychiatry 1981;44:670–676.PubMedGoogle Scholar
  76. 76.
    Clough CG, Plaitakis A, Yahr MD. Oculogyric crises and parkinsonism: a case of recent onset. Arch Neurol 1983;40:36–37PubMedGoogle Scholar
  77. 77.
    Johnson J, Lucey PA. Encephalitis lethargica, a contemporary cause of catatonic stupor: a report of two cases. Br J Psychiatry 1987;151:550–552.PubMedGoogle Scholar
  78. 78.
    Howard RS, Lees AJ. Encephalitis lethargica. A report of four recent cases. Brain 1987;110:19–33.Google Scholar
  79. 79.
    Ghaemi M, Rudolf S, Schmulling S, Bamborschke S, Heiss WD. FDG-and-Dopa-PET in postencephalitic parkinsonism. J Neural Transm 2000;1289–1295.Google Scholar
  80. 80.
    Cree BC, Bernardini GL, Hays AP. Lowe G. A fatal case of coxackievirus B4 meningoencephalitis. Arch Neurol 2003;60:107–108.PubMedCrossRefGoogle Scholar
  81. 81.
    Nath A, Jankovic J, Pettigrew LC. Movement disorders and AIDS. Neurology 1987;37:37–41.PubMedGoogle Scholar
  82. 82.
    Carranzana EJ, Rossitch E, Samuels MA. Parkinsonian symptoms in a patient with AIDS and cerebral toxoplasmosis. J Neurol Neurosurg Psychiatry 12:1445–1447Google Scholar
  83. 83.
    Navia BA, Petito CK, Gold JWM et al. Cerebral toxoplasmosis complicating the acquired immunodeficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol 1986;19:224–238.PubMedCrossRefGoogle Scholar
  84. 84.
    Noel S, Gaillaume MP, Telerman-Toppet N et al. Movement disorders due to cerebral Toxoplasma gondii infection in patients with the acquired immunodeficiency syndrome (AIDS). Acta Neurol Belg 1992;92:148–156.PubMedGoogle Scholar
  85. 85.
    Maggi P, de Mari M, Moramarco A, Fiorentino P, Lamberti P, Angarano G. Parkinsonism in a patient with AIDS and cerebral opportunistic granulomatous lesions. Neurol Sci 2002;21:173–176.CrossRefGoogle Scholar
  86. 86.
    De Mattos JP, Rosso AL, Correa RD, et al. Involuntary movements and AIDS: report of seven cases and review of the literature. Arq Neuropsiquiatr 1993;51:491–497.PubMedGoogle Scholar
  87. 87.
    Misattari SM, Power C, Nath A. Parkinsonism with HIV INFECTION. Mov Disord 1998;13:684–689.CrossRefGoogle Scholar
  88. 88.
    Cardoso F. HIV-related movement disorders. Epidemiology, pathogenesis and management. CNS Drugs 2002;16:663–668.PubMedCrossRefGoogle Scholar
  89. 89.
    Sandyk R. Parkinsonism secondary to neurosyphilis. A case report. S Afr Med J 1983;23:665–656.Google Scholar
  90. 90.
    Garcia-Moreno JM, Izquierdo G, Chacon J, Angulo S, Borobio MV. Neuroborreliosis in a patient with progressive supranuclear paralysis. An association or a cause? Rev Neurol 1997;25:1919–1921.PubMedGoogle Scholar
  91. 91.
    Zambrino CA, Zorzi G, Lanzi G, Uggetti C, Egitto MC. Bilateral striatal necrosis associated with mycoplasma pnuemoniae infection in an adolescent: clinical and neurodiagnostic follow up. Mov Disord 2000;15:1023–1026.PubMedCrossRefGoogle Scholar
  92. 92.
    Al-Mateen M, Gibbs M, Dietrch R, Mitchell WG, Menkes JH. Encephalitis lethargica-like illness in a girl with mycoplasma infection. Neurology 1988;38:1155–1158.PubMedGoogle Scholar
  93. 93.
    Saitoh S. Wada T. Narita M, et al. Mycoplasma pneumoniae infection may cause striatal lesions leading to acute neurological dysfunction. Neurology 1993;43:2150–2151.PubMedGoogle Scholar
  94. 94.
    Kim JS, Choi IS, Lee MC. Reversible parkinsonism and dystonia following probable mycoplasma pneumoniae infection. Mov Disord 1995;10:510–512.PubMedCrossRefGoogle Scholar
  95. 95.
    Brandel J, Noseda G, Agid Y. Mycoplasma pneumoniae postinfectious encephalomyelitis with bilateral striatal necrosis. Mov Disord 1996;11:333–335.PubMedCrossRefGoogle Scholar
  96. 96.
    Singer C, Berger JR, Bowen BC, Bruce JH, Weiner WJ. Akinetic-rigid syndrome in a 13-year old girl with HIV-related progressive multifocal leukoencephalopathy. Mov Disord 1993;8:113–116.PubMedCrossRefGoogle Scholar
  97. 97.
    Werring DJ, Chaudhuri KR. HIV-related progressive multifocal leukoencephalopathy presenting with an akinetic-rigid syndrome. Mov Disord 1996;11:758–761.PubMedCrossRefGoogle Scholar
  98. 98.
    De la Fuente J, Bordon J, Moreno JA, et al. Parkinsonism in an HIV-infected patient with hypodense cerebral lesion. Tuber Lung Dis 1996;77:191–192.CrossRefGoogle Scholar
  99. 99.
    Strong G. Parkinson’s syndrome following herpes ophthalmicus. Br Med J 1952;1:533.PubMedGoogle Scholar
  100. 100.
    Fenichel GM. Postvaccinal parkinsonism. Mov Disord 1993;8:253.PubMedGoogle Scholar
  101. 101.
    Reijneveld JC, Taphoorn MJB, Hoogenraad TU, Van Gijn J. Severe but transient parkinsonism after tetanus vaccination. J Neurol Neurosurg Psychiatry 1997;63:258–259.PubMedCrossRefGoogle Scholar
  102. 102.
    McCall S, Henry JM, Reid AH, Taubenberger JK. Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic parkinson cases. J Neuropathol Exp Neurol 2001;60:696–704.PubMedGoogle Scholar
  103. 103.
    Krusz JC, Koller WC, Ziegler DK. Historical Review: abnormal movements associated with epidemic encephalitis lethargica. Mov Disord 1987;2:137–141.PubMedCrossRefGoogle Scholar
  104. 104.
    Elizan TS, Casals J. Astrogliosis in von Economo’s and postencephalitic Parkinson’s diseases supports probable viral etiology. J Neurol Sci 1991;105:131–134.PubMedCrossRefGoogle Scholar
  105. 105.
    Hof PR, Charpiot A, Delacourte A, et al. Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism. Neurosci Lett 1992;139:10–14.PubMedCrossRefGoogle Scholar
  106. 106.
    Josephs KA, Parisi JE, Dickson DW. Alpha-synuclein studies are negative in postencephalitic parkinsonism of von Economo. Neurology 2002;59:645–646.PubMedGoogle Scholar
  107. 107.
    Ikeda K, Akiyama H, Kondo H, Ikeda K. Anti-tau-positive glial fibrillary tangles in the brain of postencephalitic parkinsonism of Economo type. Neurosci Lett 1993;162:176–178.PubMedCrossRefGoogle Scholar
  108. 108.
    Wong KT, Allen IV, McQuaid S, McConnell R. An immunohistochemical study of neurofibrillary tangle formation in post-encephalitic parkinsonism. Clin Neuropathol 1996;15:22–25.PubMedGoogle Scholar
  109. 109.
    Shen WC, Ho YJ, Lee SK, Lee KR. MRI of Transient post-encephalitic parkinsonism. J Comp Assist Tomo 1994;18:155–159.CrossRefGoogle Scholar
  110. 110.
    Caparros-Lefebvre D, Cabaret M, Godefroy O, et al. PET study and neuropsychological assessment of a long-lasting post-encephalitic parkinsonism. J Neural Transm 1998;105:489–495.PubMedCrossRefGoogle Scholar
  111. 111.
    Solbrig MV, Nashef L. Acute parkinsonism in suspected herpes simplex encephalitis. Mov Disord 1993;8:233–234.PubMedCrossRefGoogle Scholar
  112. 112.
    Savant CS, Singhal BS, Jankovic J, Khan MAK, Virani A. Substantia nigra lesions in viral encephalitis. Mov Disord 2003;18:213–227.PubMedCrossRefGoogle Scholar
  113. 113.
    Alves RSC, Barbosa ER, Scaff M. Postvaccinal parkinsonism. Mov Disord 1992;7:178–180.PubMedCrossRefGoogle Scholar
  114. 114.
    Calne DB, Stern GM, Laurence DR. L-dopa in postencephalitic parkinsonism. Lancet 1969;1:744–746.PubMedCrossRefGoogle Scholar
  115. 115.
    Sacks O. Awakenings. Harper Perennial, New York: 1990.Google Scholar
  116. 116.
    Duvoisin RC, Lobo-Antunes J, Yahr MD. Response of patients with post-encephalitic parkinsonism to levodopa. J Neurol Neurosurg Psychiatry 1972;35:487–495.PubMedGoogle Scholar
  117. 117.
    Walters JH. Postencephalitic parkinson syndrome after meningoencephalitis due to coxackie virus group B, type 2. N Engl J Med 1960;263:744–747.CrossRefGoogle Scholar
  118. 118.
    Posner CM, Huntley CJ, Poland JD. Para-encephalitic parkinsonism. Acta Neurol Scand 1969;45:199–215.CrossRefGoogle Scholar
  119. 119.
    Hsieh JC, Lue KH, Lee YL. Parkinson-like syndrome as the major presenting symptom of Epstein-Barr virus encephalitis. Arch Dis Child 2002;87:358–359.PubMedCrossRefGoogle Scholar
  120. 120.
    Isgreen WP, Chutarian AM, Fahn S. Sequential parkinsonism and chorea following “mild” influenza. Trans Am Neurol Assoc 1976;101:56–59.PubMedGoogle Scholar
  121. 121.
    Shiraki H. Goto A, Narabayashi H. Etat passe et present de l’encephalite Japonnaise au Japon. Rev Neurol (Paris) 1963;108:633–696.Google Scholar
  122. 122.
    Ishii T, Marsushita M, Hamada S. Characteristic residual neuropathological features of Japanese B encephalitis. Acta Neuropathol (Berl) 1977;38:181–186.CrossRefGoogle Scholar
  123. 123.
    Shoji H, Watanabe M, Itoh S, Kuwahara H, Hattori F. Japanese encephalitis and parkinsonism. J Neurol 1993;240:59–60.PubMedCrossRefGoogle Scholar
  124. 124.
    Pradham S, Pandey N, Shashank S, et al. Parkinsonism due to predominant involvement of the substantia nigra in Japanese encephalitis. Neurology 1999;53:1781–1786.Google Scholar
  125. 125.
    Scheid W, Ackerman R, Felgenhauer K. Lymphozytare Choriomeningitis unter dem bild der Encephalitis lethargica. Dtsch Med Wochenschr 1968;93:940–943.PubMedCrossRefGoogle Scholar
  126. 126.
    Adair CV, Gould RL, Smadel JE. Aseptic meningitis, a disease of diverse etiology. Clinical and etiological studies of 854 cases. Ann Intern Med 1953;39:675–704.PubMedGoogle Scholar
  127. 127.
    Bennett NMcK. Murray Valley encephalitis, 1947: clinical features. Med J Aust 1976;2:446–450.PubMedGoogle Scholar
  128. 128.
    Bickerstaff ER, Cloake PCP. Mesencephalitis and rhombencephalitis. Br Med J 1951;2:77–81.PubMedGoogle Scholar
  129. 129.
    Thieffrey S. Enterovirus et maladies du systeme nerveux. Revisiou critique et experience personnelle. Rev Neurol (Paris) 1963;108:753–776.Google Scholar
  130. 130.
    Barrett AM, Gairdner D, McFarlan AM. An outbreak of encephalitis possibly due to poliomyelitis virus. Br Med J 1952;1:1317–1322.PubMedGoogle Scholar
  131. 131.
    Vincent FM, Myers WG. Poliomyelitis and parkinsonism. N Engl J Med 1978;298:688–689.PubMedCrossRefGoogle Scholar
  132. 132.
    Mellon AF, Appleton RE, Gardner-Medwin D, Aynsley-Green A. Encephalitis lethargica-like illness in a 5 year old. Dev Med Child Neurol 1991;33:153–56.Google Scholar
  133. 133.
    Meyer B. Encephalitis after measles with severe parkinsonian rigidity: recovery. Br Med J 1943;1:508.PubMedGoogle Scholar
  134. 134.
    Henner K, Hanzal F. Encephalite tchecoslavaque a tiques. Rev Neurol (Paris) 1957;96:384–408.Google Scholar
  135. 135.
    Henner K, Hanzal F. Les encephalities europeenes a tiques. Rev Neurol (Paris) 1963;108:697–752.Google Scholar
  136. 136.
    Rasdel-Medvescek A, Marolt-Gomiscek M, Pouse-Trojar M, Gajsek-Zima M. Late sequelae after tick-borne meningoencephalitis in patients treated at the hospital for infectious diseases at University Medical Centre of Ljubljana during the period 1974–1975. Zentralbl Bakteriol 1980;9:281–284.Google Scholar
  137. 137.
    Cerna F, Mehrad B, Luby JP, et al. St. Louis encephalitis and the substantia nigra: M R imaging evaluation. Am J Neuroradiol 1999;20:114–118.Google Scholar
  138. 138.
    Wasay M, Diaz-Arastia R, Suss R, et al. St. Louis encephalitis: a review of 11 cases in a 1995 Dallas, Texas epidemic. Arch Neurol 2000;57:114–118.PubMedCrossRefGoogle Scholar
  139. 139.
    Finley KH. Postencephalitic manifestations of viral encephalitides. In: Fields WS, Blattner RJ, eds. Viral Encephalitis. CC Thomas, Springfield, IL: 1958;69–94.Google Scholar
  140. 140.
    Finley KH, Riggs N. Convalescence and sequelae. In: Monath TP, ed. St. Louis Encephalitis. American Public Health Association, Washington, DC: 1980;535–550.Google Scholar
  141. 141.
    Fulton JC, Burton AN. After effects of WEE infection in man. Canad MAJ 1953;69:268–272.Google Scholar
  142. 142.
    Mulder DW, Parrot M, Thaler M. Sequelae of western equine encephalitis. Neurology 1951;1:318–327.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2005

Authors and Affiliations

  • Hubert H. Fernandez
    • 1
  • Joseph H. Friedman
    • 1
  1. 1.Department of Clinical NeurosciencesBrown University School of MedicineProvidence

Personalised recommendations